HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 6 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TEALWOOD ASSET MANAGEMENT INC | 44,623 | $1,649 | 0.79% |
FCF Advisors LLC | 20,773 | $767,770 | 0.22% |
EXCHANGE TRADED CONCEPTS, LLC | 14,129 | $522,208 | 0.01% |
MASSMUTUAL TRUST CO FSB/ADV | 833 | $30,788 | 0.00% |
M&R CAPITAL MANAGEMENT INC | 32 | $1,183 | 0.00% |
Versant Capital Management, Inc | 21 | $776 | 0.00% |
External links
This page lists HALOZYME THERAPEUTICS INC's shareholders in Q4 2023. To view HALOZYME THERAPEUTICS INC's shareholder history, click here.